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Abstract
Background: The major virulence factors determining the pathogenicity of streptococcal strains include M protein
encoded by emm and emm-like (emmL) genes and superantigens. In this study, the distribution of emm, emmL
and superantigen genes was analyzed among the streptococcal strains isolated from the patients of acute
pharyngitis.
Methods: The streptococcal strains were isolated from the throat swabs of 1040 patients of acute pharyngitis. The
emm and emmL genes were PCR amplified from each strain and sequenced to determine the emm types. The dot-
blot hybridization was performed to confirm the pathogens as true emm nontypeable strains. The presence of
eleven currently known superantigens was determined in all the strains by multiplex PCR.
Results: Totally, 124 beta-hemolytic streptococcal strains were isolated and they were classified as group A
streptococcus (GAS) [15.3% (19/124)], group C streptococcus (GCS) [59.7% (74/124)] and group G streptococcus (GGS)
[25.0% (31/124)]. Among 124 strains, only 35 strains were emm typeable and the remaining 89 strains were emm
nontypeable. All GAS isolates were typeable, whereas most of the GCS and GGS strains were nontypeable. These
nontypeable strains belong to S. anginosus [75.3% (67/89)] and S. dysgalactiae subsp. equisimilis [24.7% (22/89)]. The
emm and emmL types identified in this study include emm12.0 (28.6%), stG643.0 (28.6%), stC46.0 (17.0%), emm30.11
(8.5%), emm3.0 (2.9%), emm48.0 (5.7%), st3343.0 (2.9%), emm107.0 (2.9%) and stS104.2 (2.9%). Various superantigen
profiles were observed in typeable as well as nontypeable strains.
Conclusions: Multiplex PCR analysis revealed the presence of superantigens in all the typeable strains irrespective of
their emm types. However, the presence of superantigen genes in emm and emmL nontypeable strains has not been
previously reported. In this study, presence of at least one or a combination of superantigen coding genes was
identified in all the emm and emmL nontypeable strains. Thus, the superantigens may inevitably play an important role
in the pathogenesis of these nontypeable strains in the absence of the primary virulence factor, M protein.
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Background
Streptococcus pyogenes (group A streptococcus) is a
Gram-positive bacterial pathogen. Extracellular surface
molecules such as the M protein, hyaluronic acid cap-
sule and fibronectin-binding proteins allow group A
streptococcus (GAS) to adhere to, colonise, and invade
human skin and mucus membranes under different
environmental conditions [1]. GAS is the causative
agent of acute bacterial pharyngitis, scarlet fever and
impetigo [2] and is responsible for a wide variety of life
threatening diseases in humans. The chronic infections
lead to acute rheumatic fever (ARF) and rheumatic
heart disease (RHD). In recent years, the GAS infections
and associated complications are emerging in developing
countries like India. More than 60 GAS virulence factors
were identified, which were responsible for adherence to
epithelial cells, internalization, invasion, systemic toxi-
city, immune modulation and evasion, cellular or tissue
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virulence factor reported in GAS is the M protein
encoded by emm gene. The M protein confers resistance
to phagocytosis by polymorphonuclear leukocytes [4]
and binds to complement control factors and thereby
prevents the activation of alternate complement pathway
[1]. The GAS produces serum opacity factor (SOF) both
in extracellular and membrane-bound form [5], which is
involved in GAS-host cell adherence process [6].
In 1935, group C streptococcus (GCS) and group G
streptococcus (GGS) were first identified as human
pathogens [7]. The infections with GCS and GGS can
also cause acute pharyngitis, necrotizing fasciitis, sepsis,
soft tissue infections and streptococcal toxic shock-like
syndrome [8]. S. dysgalactiae subsp. equisimilis and S.
anginosus are the two important species of GCS/GGS
groups. Streptococcus dysgalactiae subsp. equisimilis can
cause the whole spectrum of infections caused by S. pyo-
genes [9,10]. A high rate of pharyngeal carriage of GCS
and GGS in acute rheumatic fever (ARF) patients has
also been reported [11].
GAS, GCS and GGS possess common virulence
mechanisms including the expression of streptokinase,
hyaluronidase, C5a peptidase and M protein [12].
Recently, the presence of GAS virulence genes encoding
streptolysin S and glyceraldehyde-3-phosphate dehydro-
genase has been reported in bovine S. dysgalactiae
subsp. dysgalactiae (GCS) and human S. dysgalactiae
subsp. equisimilis (GCS/GGS) [13]. Several reports indi-
cated that GCS and GGS also possess emm or emmL
genes [12,14]. The existence of a considerable level of
emm gene sequence homology between GAS and GCS/
GGS groups has been reported [15]. The emmL gene
polymorphisms have also been identified in human GGS
isolates [6]. Several emm and emmL types of strepto-
cocci have been reported in India [16].
GAS produces many pyrogenic exotoxins, called strep-
tococcal pyrogenic exotoxins (SPEs). These toxins act as
superantigens (SAgs), which are potent T cell mitogens.
Superantigens simultaneously bind to MHC class II anti-
gens and T cell receptor (TCR) molecules and stimulate
T cells to increase the levels of the cytokines TNF-a
and IL-1b and T cell mediators like IL-2 and IFN-g [17].
These cytokines in high concentration cause fever and
shock [18].
T h ep r e s e n ts t u d yd e s c r i b e st h ep r e v a l e n c eo femm,
emmL and SAg genes in the pharyngeal GAS, GCS and
GGS strains isolated from a hospital in Tamil Nadu
State, India. An attempt was made to determine the rela-
tionship between the superantigen profiles and emm
types of pharyngeal streptococci. The strains that possess
emm or emmL genes are referred to as typeable strains
and the strains lacking emm or emmL genes are referred
to as nontypeable strains. The presence of superantigen
genes has been previously reported in typeable GAS,
GCS and GGS strains. The presence of two GAS super-
antigens, streptococcal mitogenic exotoxin Z (smeZ)a n d
streptococcal superantigen (ssa) has been reported in
GGS emm types, st245 and stG480 [19]. The presence of
GAS superantigen, streptococcal pyrogenic exotoxin M
(speM), is detected in GGS emm type, stG10 and GCS
emm type, stC1400 [19-21]. However, the presence of
superantigen genes in nontypeable strains has not been
previously reported. Here, we report the occurrence of
different superantigen genes in typeable as well as non-
typeable strains of pathogenic streptococci.
Methods
Strain collection and identification
Bacterial strains were isolated over a period of one-year
from January to December 2009 from Govt. District Head-
quarters Hospital, Virudhunagar, Tamil Nadu, India. A
total of 1040 outpatients of Pediatrics Department between
the age of 4 and 12 years with sore throat as their primary
complaint were selected. Throat swabs were collected by
swabbing the throat in the area of tonsils. The swabs were
inoculated immediately on 5% sheep blood agar and the
plates were incubated in 5 to 7% CO2 at 35°C for over-
night. The isolates were Lancefield serogrouped using
HiStrep latex test kit (Hi-Media Laboratories Pvt. Ltd.,
Mumbai, India) according to the manufacturer’s instruc-
tions. Pyrrolidonylarylamidase (PYR) test was performed
for the differentiation of S. pyogenes from S. dysgalactiae
subsp. equisimilis, S. equi subsp. zooepidemicus and S. angi-
nosus. Acid production from trehalose and sorbitol was
used to differentiate S. dysgalactiae subsp. equisimilis from
S. equi subsp. zooepidemicus. Voges-Proskauer test was
done for the differentiation of S. dysgalactiae subsp. equisi-
milis and S. equi subsp. zooepidemicus from S. anginosus
[10,22,23].
Bacterial strains and culture conditions
Beta-hemolytic streptococcal isolates were grown in 5%
sheep blood agar and stored in Todd-Hewitt broth with
20% glycerol at -80°C until used. Escherichia coli DH5a
(F
- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG
F80dlacZΔM15 Δ(lacZYA-argF) U169, hsdR17(rK
- mK
+),
l-) was grown in LB broth or agar medium. LB medium
supplemented with ampicillin (100 μg/ml) was used to
select transformants and maintain plasmids.
Antibiotic susceptibility test
Streptococcal isolates were screened for susceptibility to
penicillin G (10 units), ampicillin (10 μg), amoxicillin (20
μg), erythromycin (15 μg), azithromycin (15 μg), tetracy-
cline (30 μg), ceftazidime (10 μg) and ceftriaxone (30 μg)
by Kirby-Bauer disc diffusion method on Mueller-Hinton
agar supplemented with 5% sheep blood. S. pyogenes
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grown broth culture of test strain was adjusted to 0.5 Mac-
Farland’s turbidity standard, and then swabbed evenly on
the culture plate. Antibiotic discs were placed on the plate
and incubated at 37°C under an atmosphere containing 5-
7% CO2 for 18 h. Results were interpreted according to
the Clinical Laboratory Standard Institute (CLSI) guide-
lines [24].
Serum opacity factor (SOF) typing
Serum opacity factor typing of the streptococcal isolates
was done using horse serum according to the method of
WHO [25].
DNA extraction and PCR amplification of emm and emmL
genes
Genomic DNA was extracted from all the beta-hemolytic
streptococci by using spin column kit following
manufacturer’s instructions (Hi-Media Laboratories Pvt.
Ltd., Mumbai, India). The emm gene was amplified with
the “all M” primers [26] and emm2F-emm2R primers [27]
(Table 1). The emmL gene was amplified with G1F and
G1R primers [6]. All the 124 beta-hemolytic streptococci
were subjected to PCR using these three primer pairs.
PCR reactions were carried out in an Eppendorf mastercy-
cler (Eppendorf AG, Hamburg, Germany) with 35 cycles,
each cycle consisting of initial denaturation at 94°C for 5
min, denaturation at 94°C for 30 s, annealing at 52°C for
30 s, elongation at 72°C for 2 min and a final elongation at
72°C for 5 min. PCR products were resolved on 1% agar-
ose gel, stained with ethidium bromide and analyzed in gel
documentation unit (Bio-Rad, USA).
emm and emmL typing
All the amplicons were individually cloned in a PCR
cloning vector, pTZ57RT (MBI-Fermentas, St. Leon-Rot,
Table 1 List of primers used in this study
Primer Sequence (5’-3’) Reference
emm/emmL typing
primers
emm 1"all M” - F GGGGGGGGATCCATAAGGAGCATAAAAATGGCT [26]
emm 1"all M"- R GGGGGGGAATTCAGCTTAGTTTTCTTCTTTGCG
emm 2 - F TATTSGCTTAGAAAATTAA [27]
emm 2 - R GCAAGTTCTTCAGCTTGTTT
emmL - G1F AAAAATAAGGAGAAAAAATGG [5]
emmL - G1R TTTTTAGTTTTCTTCTTTGCG
Superantigen primers
speC - F GGTAAATTTTTCAACGACACACACATTAAA
speC - R TGTTGAGATTCTCCCGAAATAAATAGAT
speG - F GCTATGGAAGTCAATTAGCTTATGCAGAT
speG - R TTATGCGAACAGCCTCAGAGG
speJ - F CAATTAAATTACGCATACGAAATCATACCAGTA
speJ - R ACGAGTAAATATGTACGGAAGACCAAAAATA
speK - F TATCGCTTGCTCTATACACTACTGAGAGT
speK - R CCAAACTGTAGTATTTTCATCCGTATTAAA [21]
speL - F GGACGCAAGTTATTATGGATGCTCA
speL - R TTAAATAAGTCAGCACCTTCCTCTTTCTC
speA1-3,5-F GGTATTTGCTCAACAAGACCCCGAT
speA1-3,5-R TGTGTTTGAGTCAAGCGTTTCATTATCT
speA1-4-F CAAGAAGTATTTGCTCAACAAGACCCCA
speA1-4-R TTAGATGGTCCATTAGTATATAGTTGCTTGTTATC
speH -F TCTATCTGCACAAGAGGTTTGTGAATGTCCA
speH -R GCATGCTATTAAAGTCTCCATTGCCAAAA
speI -F AAGGAAAAATAAATGAAGGTCCGCCAT
speI -R TCGCTTAAAGTAATACCTCCATATGAATTCTTT
speM -F GCTTTAAGGAGGAGGAGGTTGATATTTATGCTCTA
speM -R CAAAGTGACTTACTTTACTCATATCAATCGTTTC
smeZ-F CAATAATTTCTCGTCCTGTGTTTGGAT
smeZ-R GATAAGGCGTCATTCCACCATAG
ssa -F AATTATTATCGATTAGTGTTTTTGCAAGTA
ssa -R AGCCTGTCTCGTACGGAGAATTATTGAACTC
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M13R primers at Macrogen, Seoul, South Korea. The
emm and emmL gene sequences were aligned online
with sequences available at the CDC database http://
www.cdc.gov/ncidod/biotech/strep/strepblasts.html to
identify the emm types.
Dot-blot analysis
The absence of emm or emmL genes in the genomes of
nontypeable strains were confirmed by dot-blot hybridiza-
tion using complete emm and emmL genes as probes.
Genomic DNA (100 ng) of all the nontypeable strains
were spotted on nylon membranes (Biodyne
® A, Pall,
USA) and immobilized by UV-cross linking. The complete
emm and emmL genes were labeled with biotin using
NEBlot phototype kit (New England BioLabs, MA, USA)
and used as the probe. Hybridization and washing steps
were performed as per the manufacturer’s instructions.
Genomic DNA samples of typeable GAS, GCS and GGS
isolates were used as positive controls. Further, the mem-
brane was processed with NEB Phototope
®-Star detection
kit to detect the presence or absence of emm and emmL
homologs. The luminescence was visualized using Chemi-
Doc imaging system (UVP, UK).
Multiplex PCR for superantigens
Multiplex PCR was performed using Qiagen multiplex
PCR kit (Qiagen, Hilden, Germany) to check the presence
of streptococcal pyrogenic exotoxin C (speC), speG, speJ,
speK, speL, speH, speI, speM, speA, streptococcal mitogenic
exotoxin Z (smeZ) and streptococcal superantigen (ssa)i n
all the streptococcal isolates with the reported primers
[21] (Table 1). PCR reactions were performed in an
Eppendorf mastercycler with 35 cycles with each
consisting of an initial denaturation at 95°C for 15 min,
denaturation at 94°C for 30 s, annealing at 57°C for 90 s,
elongation at 72°C for 90 s and final elongation at 72°C for
10 min. The reaction mixture consisted of 25 μlo f2 X
Qiagen multiplex PCR master mix, 2 mM of primer mix
(adjusted to 5 μl), 200 ng of template DNA (adjusted to 5
μl) and the final volume was adjusted to 50 μl using sterile
deionized water. PCR products were resolved on a 2%
(w/v) agarose gel and analyzed as described above.
Nucleotide submissions
The identified emm and emmL gene sequences were sub-
mitted to GenBank database under the accession numbers
HM125069-HM125081, HM449040-HM449043.
Results
Characteristics of streptococcal isolates
In the present study, 124 beta-hemolytic streptococcal
strains were isolated and they were classified as group
A streptococcus (GAS) [15.3% (19/124)], group C
streptococcus (GCS) [59.7% (74/124)] and group G
streptococcus (GGS) [25.0% (31/124)]. Within GCS
strains, 22 isolates were identified as S. dysgalactiae
subsp. equisimilis and 52 as S. anginosus.I nG G S ,1 6
isolates were identified as S. dysgalactiae subsp. equisi-
milis and 15 were identified as S. anginosus (Table 2).
Antibiotic susceptibility pattern of all 124 streptococcal
strains revealed that all of them were sensitive to peni-
cillin G and all other tested antibiotics.
emm and emmL typing
Among the 124 strains analyzed, only 35 of the strains
w e r ef o u n dt ob ep o s i t i v ef o re i t h e remm or emmL typ-
ing identified by the PCR amplification of emm or
Table 2 emm and emmL typeable and nontypeable pharyngeal streptococci isolated in this study
emm or emmL type No. of isolates of:
S. pyogenes S. dysgalactiae
subsp. equisimilis
S. anginosus
GAS GCS GGS GCS GGS
emm12.0 10 10 (8.1)
stG643.0 10 10 (8.1)
stC46.0 6 6 (4.8)
emm30.11 3 3 (2.4)
emm3.0 1 1 (0.8)
emm48.0 2 2 (1.6)
st3343.0 1 1 (0.8)
emm107.0 1 1 (0.8)
stS104.2 1 1 (0.8)
Nontypeable 0 16 6 52 15 89 (71.8)
Subtotal 19 22 16 52 15
Total for 19 38 67 124
species
GAS, Group A streptococci; GCS, Group C streptococci; GGS, Group G streptococci.
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these 35 strains, 19 (54.3%) were positive for emm gene,
while 16 (45.7%) were positive for emmL gene. All the
19 GAS strains were emm positive and hence these
strains were considered emm typeable. Of the 16 emmL
positive strains, 10 strains were of GGS and the other 6
were GCS and these strains could be considered as
emmL typeable. However, the majority of the isolates
[89/124 (71.8%)] were negative for both emm and emmL
genes. Further, to examine the presence of emm or
emmL homologs in their genomes, the dot-blot hybridi-
zation was performed with emm and emmL gene speci-
fic probes and genomic DNA. However, no detectable
signal was obtained suggesting that these strains were
truly emm nontypeable. Of these 89 nontypeable strains,
22 (24.7%) were identified as S. dysgalactiae subsp. equi-
similis and 67 (75.3%) were S. anginosus.W i t h i nt h e2 2
strains of S. dysgalactiae subsp. equisimilis,1 6s t r a i n s
were of GCS and 6 strains were of GGS. Among the 67
strains of S. anginosus, 52 were GCS and 15 were of
GGS (Table 2).
The emm or emmL typeable strains were subjected to
RFLP analysis to ascertain the emm type. RFLP analysis
of these 35 strains revealed 9 distinct patterns (data not
shown). All the amplicons regardless of their RFLP pat-
tern were cloned and sequenced. Sequence analysis
revealed that RFLP pattern and sequences were similar,
thus representing 9 emm types among the 35 typeable
strains (Table 3).
Serum opacity factor (SOF)
Among the 35 emm and emmL typeable strains, 5 of the
GAS strains that belong to emm48.0, emm107.0 and
stS104.2 were SOF-positive and the other 30 strains
were SOF-negative. Significantly, all the nontypeable
GCS and GGS strains were SOF-negative.
Superantigen profiling
The superantigen profiles (combinations of superantigen
genes) of the 124 isolates are summarized in Table 3.
The superantigen, speC, was detected in all the strains,
whereas speJ, speK, speM and ssa were detected in none
of the isolates. Among the 19 GAS typeable strains, 10
emm12 type strains were positive for speC, speG, speL,
speA1-4 and smeZ. Ten GGS typeable strains (stG643.0)
were positive for speC, speG, speA1-4 and smeZ.S i x
GCS typeable strains (stC46.0)w e r ep o s i t i v ef o rs i x
superantigens (speC, speG, speA, smeZ, speH and speI).
Table 3 Superantigen profiles of emm and emmL typeable and nontypeable strains of pharyngeal streptococci.
S.No Superantigen Profiles No. of typeable strains No. of nontypeable strains
1. speC 01
2. speC+ smeZ 06
3. speC+ speG 3( emm 30.11)0
4. speC+ speA1-3,5 1( st3343.0)0
5. speC+ speG+ speA1-4 2( emm 48.0)3
6. speC+ speG+ speA1-3,5 1( emm 107.0)1
7. speC+ speG+ speL 03
8. speC+ speG+ smeZ 01 5
9. speC+ speA1-4+ speA1-3,5 01
10. speC+ speA1-4+ smeZ 04
11. speC+ speG+ speA1-4+ speA1-3,5 1( emm3.0)3
12. speC+ speG+ speA1-4+ smeZ 10 (stG643.0)2 7
13. speC+ speG+ speL + smeZ 06
14. speC+ speG+ speL+ speI 01
15. speC+ speG+ speL+ speA1-4+ smeZ 10 (emm12.0)7
16. speC+ speG+ speA1-4+ speA1-3,5+ smeZ 01
17. speC+ speG+ speA1-4 + speH+ smeZ 01
18. speC+ speG+ speA1-4+ speA1-3,5+ speI 01
19. speC+ speG+ speH+ smeZ+ speI 01
20. speC+ speG+ speA1-4+ smeZ+ speI 01
21. speC+ speA1-4+ speH + smeZ+ speI 02
22. speC+ speG+ speA1-4+ speA1-3,5+ speH+ smeZ 01
23. speC+ speG+ speA1-4+ speA1-3,5+ speH+ speI 01
24. speC+ speG+ speL+ speA1-4+ smeZ+ speI 1( stS104.2)0
25. speC+ speG+ speA1-4+ speH+ smeZ+ speI 01
26. speC+ speG+ speA1-4+ speA1-3,5+ speH+smeZ+ speI 6( stC46.0)1
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have at least one superantigen gene (Table 3). Among
nontypeable strains, 27 were positive for speC, speG,
speA1-4 and smeZ and 15 strains were positive for speC,
speG and smeZ. Maximum of six superantigen genes
(speC, speG, speA, smeZ, speH and speI) were detected
in a single GCS nontypeable strain (S. anginosus). These
results revealed that all the typeable and nontypeable
pathogenic beta-hemolytic streptococcal isolates possess
at least one superantigen gene.
Discussion
In the present study, a total of 124 strains were isolated
from acute pharyngitis patients. Interestingly, 71.8% of
them were emm and emmL nontypeable. The emm12 was
the predominant emm type (28.6%) among the typeable
GAS strains. The prevalence of emm12 was previously
reported among the pharyngeal isolates of GAS from
Chennai, South India [29]. The presence of emm1, emm3,
emm28, emm12, emm4 and emm11 has been reported
among the North Indian GAS isolates [30].
In this study, stG643.0 was the predominant emm type
(28.6%) among GGS strains. In contrast, two other GGS
emm types, stG485 and stGLP1, were previously reported
to be prevalent among 49 GGS isolates from Chennai,
India [31]. Other emm types previously reported from
India [8] which also represented in this study were emm3
(2.9%) and stC46 (17.0%). In addition, the newly identified
emm types include emm48.0 (5.7%), st3343.0 (2.9%),
emm107.0 (2.9%), stS104.2 (2.9%), and emm30.11 (8.5%).
A c c o r d i n gt oC D C ,t h e s eemm types have already been
reported in United States, Mexico, Malaysia and New
Zealand, but not from India. Therefore, further studies on
the epidemiology of these emm types in India are needed.
The emergence of drug resistance among streptococci
to macrolides (erythromycin and clarithromycin) and tet-
racycline are widely reported in recent years [32-34].
However, in the present study, all the streptococcal
strains were susceptible to all the tested antibiotics
including b-lactams, macrolides and tetracycline. There-
fore, drug resistance is not a major threat among the
streptococci isolated in this study population. However,
untreated chronic infections may lead to severe compli-
cations such as acute rheumatic fever (ARF) and rheu-
matic heart disease (RHD).
SOF acts as an adhesin involved in the adherence of
GAS to host cells [35]. It has also been reported that the
interaction between SOF and the host extracellular
matrix protein, fibulin-1, may be involved in the adhesion
of GAS to extracellular matrices of the host [36]. Court-
ney et al. [37] reported that the SOF was expressed at a
frequency of 50% among the clinical isolates of GAS. In
contrast, only 14.3% of typeable GAS isolates were posi-
tive for SOF and all GCS and GGS strains were SOF-
negative. Similarly, McDonald et al. [15] reported that
most of the GCS and GGS strains of S. dysgalactiae
subsp. equisimilis were SOF-negative. Therefore, SOF
may not be the only factor responsible for the adhesion
of GAS to the host and some other mechanisms might
exist [37]. Some of the GAS adhesins reported other than
SOF include lipoteichoic acid, hyaluronic acid capsule,
vitronectin-binding protein and collagen-binding protein
[2].
We have observed significant differences in the distri-
bution of superantigen genes between typeable and non-
typeable strains. The co-occurance of number of
superantigen genes was relatively more in typeable than
in nontypeable strains. Among 11 superantigens, a maxi-
mum of 6 superantigens (speC, speG, speA, speH, speI
and smeZ) was detected in 17.1% of typeable strains,
whereas this combination was detected in only 1.1% non-
typeable strains. Totally, 26 superantigen profiles have
been identified among the typeable and nontypeable
strains. Of these, 23 profiles were detected in nontypeable
strains and 9 profiles in typeable strains. Only six super-
antigen profiles were identified in both typeable and non-
typeable strains. Other 20 profiles were confined to
either typeable or nontypeable strains. As reported pre-
viously [38], the most prevalent chromosomally encoded
superantingens, speG and smeZ, were detected in 97.1%
and 77.1% of the typeable strains, respectively. In addi-
tion, these two genes were detected in 84.3% and 83.1%
of nontypeable isolates, respectively. Similarly, Proft et al.
[39] have reported the presence of these two superanti-
gens in all the strains of GAS.
A high occurrence of GCS (59.7%) and GGS (25.0%)
among pharyngeal streptococcal isolates was observed,
which is in agreement with previous reports from Spain
and Australia [10,15]. It is known that more virulent
forms of GCS and GGS could have emerged through the
acquisition of superantigen genes from GAS [19]. In this
study, many superantigen profiles have been identified
among GCS and GGS strains and these strains could be
considered as emerging pathogens.
Overall, 67 S. anginosus ( 5 2G C Sa n d1 5G G S )s t r a i n s
and 22 S. dysgalactiae subsp. equisimilis (16 GCS and 6
GGS) strains were nontypeable. Although the presence of
superantigens has been reported in typeable GCS and
GGS isolates, their presence in nontypeable strains has
not been reported so far. However, in our study, com-
pared to the strains of typeable S. pyogenes (GAS) and
typeable as well as nontypeable S. dysgalactiae subsp.
equisimilis, more numbers of superantigen profiles have
been observed in nontypeable strains of S. anginosus
(GCS/GGS). In a very recent study [13], the presence of
GAS superantigens (speL, speC, speK and speM) has been
reported in typeable S. dysgalactiae subsp. dysgalactiae
(GCS) strains associated with bovine mastitis, but not in
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(GCS/GGS). We have identified the presence of superan-
tigens in nontypeable strains of S. dysgalactiae subsp.
equisimilis (GCS/GGS) associated with acute pharyngitis
i nh u m a n s .T h e r e f o r e ,o u rf i n d i n g ss u g g e s tt h a t ,l i k eS.
pyogenes, S. dysgalactiae subsp. equisimilis and S. angino-
sus may emerge as potential human pathogens. Some
other factors might be involved in the pathogenesis of
nontypeable strains in the absence of M protein. The pre-
sence of superantigens in nontypeable strains has not
been reported so far. The role of superantigens in the
pathogenesis of typeable GCS and GGS strains is well
documented [2,19,20]. However, the role of superanti-
gens in the pathogenic mechanisms of nontypeable
strains is yet to be studied.
Conclusions
A high occurrence of GCS and GGS strains of S. anginosus
and S. dysgalactiae subsp. equisimilis was observed among
the acute pharyngitis patients and most of them were non-
typeable. In addition, the presence of superantigens in
nontypeable GCS and GGS strains was observed for the
first time. Therefore, these strains may emerge as potential
human pathogens. Though antibiotic resistance was not
observed among these strains, earlier diagnosis and proper
antibiotic treatment are required to cure acute pharyngitis
and prevent from subsequent complications such as acute
rheumatic fever (ARF) and rheumatic heart disease (RHD).
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